MAXIKA HOMES (WESTWARD2) LTD
Company number 14457043 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
MAXIKA HOMES (WESTWARD2) LTD - Analysis Report
Company Number: 14457043
Analysis Date: 2025-07-20 12:05 UTC
Financial Health Assessment of MAXIKA HOMES (WESTWARD2) LTD as at 30 November 2023
1. Financial Health Score: D
Explanation:
The company exhibits symptoms of financial distress, primarily due to negative net current assets and shareholders’ funds. The balance sheet reveals a working capital deficit and accumulated losses, indicating an unhealthy liquidity position and erosion of equity. While the company is newly established (incorporated in late 2022) and operating within the real estate sector, the financial indicators suggest challenges that need urgent management attention to restore financial vitality.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Current Assets | 1,045,180 | Majority held in "stocks" (property inventory). |
| Cash at Bank | 114 | Critically low cash reserves – poor liquidity. |
| Current Liabilities | 1,103,533 | High short-term obligations to settle. |
| Net Current Assets (Working Capital) | -58,353 | Negative working capital signals liquidity strain. |
| Shareholders’ Funds (Equity) | -58,453 | Negative equity reflects accumulated losses. |
| Directors’ Loan | 59,900 | Company owes money to directors, indicating reliance on related-party funding. |
| Debt to Related Company | 235,583 | Significant debt to an affiliated company, increasing financial risk. |
Interpretation of Vital Signs:
Negative Working Capital: The business has more current liabilities than current assets, a red flag akin to a patient showing symptoms of dehydration — insufficient resources to cover immediate needs. This can cause difficulties in meeting short-term obligations and operational disruptions.
Negative Equity: The company’s net assets are below zero, indicating that liabilities exceed assets. This is analogous to a chronic illness impacting the company’s "financial immune system," weakening its ability to sustain operations without external support.
Low Cash Reserves: The minimal cash balance severely limits the ability to cover urgent expenses or capitalize on opportunities, akin to a patient with low blood sugar needing immediate supplementation.
High Stock Value: The stock is primarily property under development or held for sale, which is illiquid and subject to market risk. Post-balance sheet events reveal a forced sale at a loss, indicating potential impairment and further strain.
3. Diagnosis
MAXIKA HOMES (WESTWARD2) LTD is currently in a precarious financial condition. The company’s core problem lies in liquidity and solvency:
The negative working capital is a critical symptom of cash flow distress, suggesting the company cannot comfortably meet short-term debts with its available liquid assets.
The negative shareholders’ funds indicate that the company has been operating at a loss, eroding its capital base and potentially limiting its ability to secure financing or investment.
Reliance on director loans and related-party debt shows dependency on insiders for funding, which, while supportive, is not a sustainable long-term solution and increases risk exposure.
The sector (real estate buying, selling, and letting) involves holding significant property stock, which is illiquid and can fluctuate in value, exposing the company to market risks. The post-balance sheet loss on sale of property stock highlights this vulnerability.
The fact that the company is newly incorporated (less than 2 years old) means it is still in the early stages of its lifecycle, but the financial signs point to distress needing prompt corrective measures.
4. Prognosis
If current trends continue without intervention:
The company risks further liquidity crises, potentially becoming unable to fund operations or meet creditor demands.
Negative equity may worsen, reducing creditor confidence and making it harder to raise capital.
Continued reliance on director and related-party funding may not be sustainable and could lead to governance challenges.
However, as the directors have indicated a going concern basis and the company is not yet in liquidation or administration, there is an opportunity for recovery if corrective actions are taken swiftly.
5. Recommendations
To improve the financial wellness of MAXIKA HOMES (WESTWARD2) LTD, the following steps are advisable:
a. Improve Liquidity Management:
- Increase cash reserves by managing payables and receivables more aggressively.
- Consider short-term financing options that do not unduly increase risk.
b. Address Working Capital Deficit:
- Accelerate the sale or leasing of property stock to convert illiquid assets into cash. However, aim to avoid distress sales that crystallize losses.
- Negotiate longer payment terms with creditors where possible.
c. Strengthen Capital Base:
- Explore equity injections from existing shareholders or new investors to rebuild negative shareholders’ funds.
- Reduce reliance on director and related-party loans by formalizing funding arrangements or converting debt to equity.
d. Strategic Review:
- Evaluate the business model and project pipeline for profitability and sustainability.
- Conduct market analysis to ensure property assets align with demand trends.
e. Financial Monitoring:
- Implement robust financial reporting systems to track cash flow and solvency metrics regularly.
- Engage financial advisors to assist with restructuring if necessary.
Medical Analogy Summary
MAXIKA HOMES (WESTWARD2) LTD shows clear symptoms of financial distress—negative net current assets (liquidity dehydration) and negative equity (a weakened financial immune system). Immediate fluid resuscitation in the form of cash injections and improved asset liquidity is critical to stabilize the patient. Without timely intervention, the company risks slipping into a more severe state of financial illness that could require formal insolvency treatment.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.